CATEGORY: STRESS & MIND-BODY
You finish a full course of therapy, and the depression is still there. It’s one of the most discouraging moments in mental health care. What comes next has never been clear. A UK trial enrolled 234 adults in exactly that position and offered half of them an eight-week mindfulness course on top of their usual care. Eight months in, their depression scores were about 2.5 points lower on the 27-point questionnaire doctors use than the scores of people who got usual care alone.1
Eight Weeks of Group Sessions, by Video Call
The course was mindfulness-based cognitive therapy, or MBCT. It blends meditation practice with techniques from cognitive therapy, and it teaches people to notice the thought spirals that drag a low mood lower. Everyone in the trial had already completed at least 12 sessions of high-intensity NHS talking therapy without remission. A random draw then decided who got a course place and who didn’t, which is what makes the comparison trustworthy. Groups met by video call once a week for eight weeks, led by a trained therapist. Attendance held up well: 86% of those offered the course completed at least half the sessions.1
Two and a Half Points, Still There at Eight Months
Depression was scored on the PHQ-9, a nine-question checklist that runs from 0 to 27. A score of 10 or more signals at least moderate depression, and everyone started at 10 or above. At 34 weeks, the MBCT group sat 2.49 points lower than the usual-care group (95% CI 1.09 to 3.89 points, p=0.0006).1 The researchers describe that as a small-to-moderate effect. It’s not a cure. It is a real, lasting difference in people whose depression had already resisted a full course of treatment, and it was still visible six months after the course ended.
Under £100 a Person to Run
The economic side may matter as much as the symptom scores. Delivering the course cost less than £100 per person, and overall health and care costs came out slightly lower in the MBCT group. The analysis put the chance that the course is cost-effective by standard NHS thresholds at 99%.1 That combination is rare. A treatment helped people other treatments had missed, and it likely paid for itself.
Seven Trials Point the Same Way
Other research lands in the same place. A 2026 analysis pooled individual data from seven trials, 777 people in all, testing MBCT in difficult-to-treat depression. Against usual care, MBCT likely helps, with about a 92% probability that the benefit is clinically relevant.2 One caution came with it: when MBCT was compared against other active therapies rather than usual care, no clear difference emerged. So the honest reading is that MBCT earns a place among second-line options, not above them.
Key Takeaways
- Depression that survives a full course of talking therapy may still respond to a different approach; this trial found meaningful improvement from an eight-week mindfulness course added to usual care.
- The benefit was about 2.5 points on the 27-point PHQ-9 depression scale, a small-to-moderate effect that persisted six months after the course ended.
- The course cost under £100 per person to deliver and was judged 99% likely to be cost-effective for the NHS.
- Pooled data from seven trials back the finding against usual care, though MBCT hasn’t been shown to beat other active therapies.
References
- Barnhofer T, Dunn BD, Strauss C, et al. Mindfulness-based cognitive therapy versus treatment as usual after non-remission with NHS Talking Therapies high-intensity psychological therapy for depression: a UK-based clinical effectiveness and cost-effectiveness randomised, controlled, superiority trial. The Lancet Psychiatry. 2025;12(6):433–446. link
- Barnhofer T, Niemi M, Michalak J, et al. Efficacy and Moderators of Mindfulness-Based Cognitive Therapy in Difficult-to-Treat Depression: A Systematic Review and Individual Participant Data Meta-Analysis. Psychotherapy and Psychosomatics. 2026:1–16. link